Lilly's Prevail, Capsida partner to develop gene therapies for nervous system diseases

cafead

Administrator
Staff member
  • cafead   Jan 04, 2023 at 05:42: PM
via Prevail Therapeutics, the gene therapy-focused subsidiary of Eli Lilly announced a partnership with biotechnology company Capsida Biotherapeutics to develop genetic medicines for central nervous system diseases.

article source
 

<